5-(4-羟基苯基)戊酸甲酯 | 64201-30-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 中文名称: 5-(4-羟基苯基)戊酸甲酯
• 英文名称: 5-(4-hydroxyphenyl)pentanoic acid methyl ester
• 英文别名: methyl 5-(4-hydroxyphenyl)-4-pentanoate；methyl 5-(4-hydroxyphenyl)pentanoate；Methyl-δ-(p-(2-hydroxyphenyl)valerat
• CAS: 64201-30-5
• 化学式: C₁₂H₁₆O₃
• 分子量: 208.257
• InChiKey: VRPBPRWMUAQEJY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  15
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2918290000

反应信息

• 作为反应物：
  描述：

  5-(4-羟基苯基)戊酸甲酯 在 sodium hydroxide 作用下， 以 甲醇 为溶剂， 以100%的产率得到5-(4-羟基苯基)戊酸
  参考文献：
  名称：

  Initial structure–activity relationship of a novel class of nonpeptidyl GnRH receptor antagonists: 2-arylindoles

  摘要：

  A nonpeptidyl GnRH receptor antagonist (1), with a unique 2-arylindole core, was identified through the Merck inhouse screening for binding affinity on the rat GnRH receptor. SAR studies directed toward the alkoxy-ethanolamine and 2-aryl groups resulted in a simpler lead structure with improved activity. This compound 50 exhibits a 60-fold improvement in binding activity over our initial lead 1. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(00)00707-1
• 作为产物：
  描述：

  3-[4-(苄氧基)苯基]丙酸 在 palladium dihydroxide 氢气 、 二甲羟胺盐酸盐 、 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 甲醇 、 二氯甲烷 、 乙酸乙酯 为溶剂， 生成 5-(4-羟基苯基)戊酸甲酯
  参考文献：
  名称：

  Initial structure–activity relationship of a novel class of nonpeptidyl GnRH receptor antagonists: 2-arylindoles

  摘要：

  A nonpeptidyl GnRH receptor antagonist (1), with a unique 2-arylindole core, was identified through the Merck inhouse screening for binding affinity on the rat GnRH receptor. SAR studies directed toward the alkoxy-ethanolamine and 2-aryl groups resulted in a simpler lead structure with improved activity. This compound 50 exhibits a 60-fold improvement in binding activity over our initial lead 1. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(00)00707-1

文献信息

• Composition and kit comprising piperazine derivatives and metformin, and use thereof in the treatment of diabetes
  申请人：METABOLYS

  公开号：US20150297539A1

  公开（公告）日：2015-10-22

  The present invention relates to a composition comprising, in combination, metformin or a salt thereof, a pharmaceutically acceptable carrier or excipient and at least one compound of formula (I), the enantiomers, diastereoisomers or pharmaceutically acceptable salts thereof. Formula (I). The present invention also relates to the use of said composition for the treatment of diseases associated with insulin resistance syndrome.

  本发明涉及一种组合物，其包括甲双胍或其盐、药学上可接受的载体或赋形剂以及至少一种式（I）的化合物，其对映体、非对映异构体或药学上可接受的盐。式（I）。本发明还涉及所述组合物用于治疗与胰岛素抵抗综合征相关疾病。
• PIPERAZINE DERIVATIVES, METHODS FOR PREPARING SAME, AND USES THEREOF IN THE TREATMENT OF INSULIN RESISTANCE
  申请人：Moinet Gerard

  公开号：US20140155409A1

  公开（公告）日：2014-06-05

  The invention relates to a compound of formula (I), where R 1 , R 2 , R 3 , m, n, and L 1 are as defined in claim 1, to the methods for preparing same, to the pharmaceutical compositions containing same, and to the uses thereof in the treatment of diseases associated with insulin resistance syndrome.

  本发明涉及一种式（I）的化合物，其中R1、R2、R3、m、n和L1的定义如权利要求书中所定义，以及制备该化合物的方法、含有该化合物的药物组合物以及其在治疗与胰岛素抵抗综合征相关的疾病中的应用。
• COMPOUNDS
  申请人：GORE Martin Paul

  公开号：US20080039444A1

  公开（公告）日：2008-02-14

  The present invention relates to compounds of formula (I), and salts thereof, processes for their preparation, to compositions containing them and to their use in the treatment of various disorders, such as allergic rhinitis.

  本发明涉及式(I)化合物及其盐，其制备过程，含有它们的组合物以及它们在治疗各种疾病（如过敏性鼻炎）中的用途。
• 2-Substituted 4-Benzylphthalazinone Derivatives as Histamine H1 and H3 Antagonists
  申请人：Gore Paul Martin

  公开号：US20090105225A1

  公开（公告）日：2009-04-23

  The present invention relates to compounds of formula (I), and salts thereof, processes for their preparation, to compositions containing them and to their use in the treatment of various disorders, such as allergic rhinitis.

  本发明涉及公式(I)的化合物及其盐，其制备方法，含有它们的组合物以及它们在治疗各种疾病，如过敏性鼻炎中的应用。
• G-Protein-Conjugated Receptor Agonist
  申请人：Tsujimoto Gozoh

  公开号：US20110184031A1

  公开（公告）日：2011-07-28

  Disclosed is a novel aralkyl carboxylic acid compound which has an agonistic activity on GPR-120 and/or GPR-40, particularly GPR-120, and is therefore useful as an appetite regulator, an anti-obesity agent, a therapeutic agent for diabetes, a pancreatic beta differentiating cell growth enhancer, a therapeutic agent for metabolic syndrome, a therapeutic agent for a gastrointestinal disease, a therapeutic agent for a neuropathy, a therapeutic agent for a mental disorder, a therapeutic agent for a pulmonary disease, a therapeutic agent for a pituitary hormone secretion disorder or a lipid flavoring/seasoning agent. The aralkyl carboxylic acid compound is represented by the general formula (I). (I) wherein the ring Q represents a pyridyl or the like; R 1 represents a C 1-6 alkyl group or the like; R 2 represents a hydrogen atom, a C 1-4 alkyl group or a C 1-4 alkoxy group; m and n independently represent an integer of 1 to 5; and X represents an oxygen atom, a sulfur atom or —NR 3 — [wherein R 3 represents a hydrogen atom or a C 1-4 alkyl group].

  本发明揭示了一种新型的芳基羧酸化合物，其具有对GPR-120和/或GPR-40，特别是GPR-120的激动活性，因此可用作食欲调节剂、抗肥胖剂、糖尿病治疗剂、胰岛素分化细胞生长增强剂、代谢综合征治疗剂、胃肠疾病治疗剂、神经病治疗剂、精神障碍治疗剂、肺部疾病治疗剂、垂体激素分泌障碍治疗剂或脂肪调味/调料剂。芳基羧酸化合物由通式（I）表示。其中，环Q表示吡啶基或类似物；R1表示C1-6烷基或类似物；R2表示氢原子、C1-4烷基或C1-4烷氧基；m和n独立地表示1至5的整数；X表示氧原子、硫原子或-NR3- [其中R3表示氢原子或C1-4烷基]。